Lauren Averett Byers (Lauren Byers, Lauren A Byers)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 30

Top Topics

Network Analysis

Small Cell Lung Cancer

Top Venues

Research square

Nature medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

NPJ precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Jia Wu, Muhammad Aminu, Lingzhi Hong, Natalie I Vokes, Stephanie Tzouanas Schmidt, Maliazurina B Saad, Bo Zhu, Xiuning Li, Cascone Tina, Ajay Sheshadri, David Jaffray, P Andrew Futreal, Jiun-Kae Jack Lee, Lauren Averett Byers, Don L Gibbons, John Victor Heymach, Ken Chen, Chao Cheng, Jianjun Zhang, Bo Wang
Joint multi-omics discriminant analysis with consistent representation learning using PANDA. Research square (2024)
Muhammad Aminu, Bo Zhu, Natalie Vokes, Hong Chen, Lingzhi Hong, Jianrong Li, Junya Fujimoto, Yuqui Yang, Tao Wang, Bo Wang, Alissa Poteete, Monique B Nilsson, Xiuning Le, Cascone Tina, David Jaffray, Nicholas E Navin, Lauren Averett Byers, Don L Gibbons, John Victor Heymach, Ken Chen, Chao Cheng, Jianjun Zhang, Jia Wu
CoCo-ST: Comparing and Contrasting Spatial Transcriptomics data sets using graph contrastive learning. Research square (2024)
C Allison Stewart, Lixia Diao, Yuanxin Xi, Runsheng Wang, Kavya Ramkumar, Alejandra Griselda Serrano, Azusa Tanimoto, B Leticia Rodriguez, Benjamin B Morris, Li Shen, Bingnan Zhang, Yan Yang, Samera H Hamad, Robert J Cardnell, Alberto Duarte, Moushumi Sahu, Veronica Y Novegil, Bernard E Weissman, Michael Frumovitz, Neda Kalhor, Luisa Maren Solis Soto, Pedro Rocha, Natalie I Vokes, Don L Gibbons, Jing Wang, John Victor Heymach, Bonnie Glisson, Lauren Averett Byers, Carl M Gay
YAP1 status defines two intrinsic subtypes of LCNEC with distinct molecular features and therapeutic vulnerabilities. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Jia Wu, Muhammad Aminu, Bo Zhu, Natalie Vokes, Hong Chen, Lingzhi Hong, Jianrong Li, Junya Fujimoto, Alissa Poteete, Monique Nilsson, Xiuning Li, Tina Cascone, David Jaffray, Nicholas E Navin, Lauren Averett Byers, Don L Gibbons, John Victor Heymach, Ken Chen, Chao Cheng, Jianjun Zhang, Yuqui Yang, Tao Wang, Bo Wang
CoCo-ST: Comparing and Contrasting Spatial Transcriptomics data sets using graph contrastive learning. Research square (2024)
C Allison Stewart, Lixia Diao, Yuanxin Xi, Runsheng Wang, Kavya Ramkumar, Alejandra Griselda Serrano, Azusa Tanimoto, B Leticia Rodriguez, Benjamin B Morris, Li Shen, Bingnan Zhang, Yan Yang, Samera H Hamad, Robert J Cardnell, Alberto Duarte, Moushumi Sahu, Veronica Y Novegil, Bernard E Weissman, Michael Frumovitz, Neda Kalhor, Luisa Maren Solis Soto, Pedro Rocha, Natalie I Vokes, Don L Gibbons, Jing Wang, John Victor Heymach, Bonnie Glisson, Lauren Averett Byers, Carl M Gay
YAP1 status defines two intrinsic subtypes of LCNEC with distinct molecular features and therapeutic vulnerabilities. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Muhammad Aminu, Lingzhi Hong, Natalie I Vokes, Stephanie Tzouanas Schmidt, Maliazurina Saad, Bo Zhu, Xiuning Li, Cascone Tina, Ajay Sheshadri, Bo Wang, David Jaffray, P Andrew Futreal, Jiun-Kae Jack Lee, Lauren Averett Byers, Don L Gibbons, John Victor Heymach, Ken Chen, Chao Cheng, Jianjun Zhang, Jia Wu
Joint multi-omics discriminant analysis with consistent representation learning using PANDA. Research square (2024)
Muhammad Aminu, Lingzhi Hong, Natalie I Vokes, Stephanie Tzouanas Schmidt, Maliazurina Saad, Bo Zhu, Xiuning Li, Cascone Tina, Ajay Sheshadri, Bo Wang, David Jaffray, P Andrew Futreal, Jiun-Kae Jack Lee, Lauren Averett Byers, Don L Gibbons, John Victor Heymach, Ken Chen, Chao Cheng, Jianjun Zhang, Jia Wu
Joint multi-omics discriminant analysis with consistent representation learning using PANDA. Research square (2024)
Kavya Ramkumar, Azusa Tanimoto, Carminia Maria Della Corte, C Allison Stewart, Qi Wang, Li Shen, Robert J Cardnell, Jing Wang, Urszula M Polanska, Courtney L Andersen, Jamal Saeh, J Elizabeth Pease, Jon Travers, Giulia Fabbri, Carl M Gay, Jelena Urosevic, Lauren Averett Byers
Targeting BCL2 overcomes resistance and augments response to aurora kinase B inhibition by AZD2811 in small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Cascone Tina, Cheuk H Leung, Annikka Weissferdt, Apar Pataer, Brett W Carter, Myrna C B Godoy, Hope Feldman, William N William, Yuanxin Xi, Sreyashi Basu, Jing Jing Sun, Shalini S Yadav, Frank R Rojas Alvarez, Younghee Lee, Aditya K Mishra, Lili Chen, Monika Pradhan, Haiping Guo, Ansam Sinjab, Nicolas Zhou, Marcelo Vailati Negrão, Xiuning Li, Carl M Gay, Anne S Tsao, Lauren Averett Byers, Mehmet Altan, Bonnie S Glisson, Frank V Fossella, Yasir Y Elamin, George Blumenschein, Jianjun Zhang, Ferdinandos Skoulidis, Jia Wu, Reza J Mehran, David C Rice, Garrett L Walsh, Wayne L Hofstetter, Ravi Rajaram, Mara B Antonoff, Junya Fujimoto, Luisa Maren Solis Soto, Edwin Roger Parra Cuentes, Cara L Haymaker, Ignacio I Wistuba, Stephen G Swisher, Ara A Vaporciyan, Heather Y Lin, Jing Wang, Don L Gibbons, Jiun-Kae Jack Lee, Nadim J Ajami, Jennifer A Wargo, James P Allison, Padmanee Sharma, Humam Kadara, John Victor Heymach, Boris Sepesi
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial. Nature medicine 29 (3) (2023)
Blessie Elizabeth Nelson, Jason Roszik, Filip Janku, David S Hong, Shumei Kato, Aung Naing, Sarina Piha-Paul, Siqing Fu, Apostolia-Maria Tsimberidou, Maria Cabanillas, Naifa Lamki Busaidy, Milind Javle, Lauren Averett Byers, John Victor Heymach, Funda Meric-Bernstam, Vivek Subbiah
BRAF v600E-mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study. NPJ precision oncology 7 (1) (2023)
Cascone Tina, Cheuk H Leung, Annikka Weissferdt, Apar Pataer, Brett W Carter, Myrna C B Godoy, Hope Feldman, William N William, Yuanxin Xi, Sreyashi Basu, Jing Jing Sun, Shalini S Yadav, Frank R Rojas Alvarez, Younghee Lee, Aditya K Mishra, Lili Chen, Monika Pradhan, Haiping Guo, Ansam Sinjab, Nicolas Zhou, Marcelo Vailati Negrão, Xiuning Li, Carl M Gay, Anne S Tsao, Lauren Averett Byers, Mehmet Altan, Bonnie S Glisson, Frank V Fossella, Yasir Y Elamin, George Blumenschein, Jianjun Zhang, Ferdinandos Skoulidis, Jia Wu, Reza J Mehran, David C Rice, Garrett L Walsh, Wayne L Hofstetter, Ravi Rajaram, Mara B Antonoff, Junya Fujimoto, Luisa Maren Solis Soto, Edwin Roger Parra Cuentes, Cara L Haymaker, Ignacio I Wistuba, Stephen G Swisher, Ara A Vaporciyan, Heather Y Lin, Jing Wang, Don L Gibbons, Jiun-Kae Jack Lee, Nadim J Ajami, Jennifer A Wargo, James P Allison, Padmanee Sharma, Humam Kadara, John Victor Heymach, Boris Sepesi
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial. Nature medicine (2023)
Blessie Elizabeth Nelson, Jason Roszik, Filip Janku, David S Hong, Shumei Kato, Aung Naing, Sarina Piha-Paul, Siqing Fu, Apostolia-Maria Tsimberidou, Maria Cabanillas, Naifa Lamki Busaidy, Milind Javle, Lauren Averett Byers, John Victor Heymach, Funda Meric-Bernstam, Vivek Subbiah
BRAF v600E-mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study. NPJ precision oncology 7 (1) (2023)
Cascone Tina, Cheuk H Leung, Annikka Weissferdt, Apar Pataer, Brett W Carter, Myrna C B Godoy, Hope Feldman, William N William, Yuanxin Xi, Sreyashi Basu, Jing Jing Sun, Shalini S Yadav, Frank R Rojas Alvarez, Younghee Lee, Aditya K Mishra, Lili Chen, Monika Pradhan, Haiping Guo, Ansam Sinjab, Nicolas Zhou, Marcelo Vailati Negrão, Xiuning Li, Carl M Gay, Anne S Tsao, Lauren Averett Byers, Mehmet Altan, Bonnie S Glisson, Frank V Fossella, Yasir Y Elamin, George Blumenschein, Jianjun Zhang, Ferdinandos Skoulidis, Jia Wu, Reza J Mehran, David C Rice, Garrett L Walsh, Wayne L Hofstetter, Ravi Rajaram, Mara B Antonoff, Junya Fujimoto, Luisa Maren Solis Soto, Edwin Roger Parra Cuentes, Cara L Haymaker, Ignacio I Wistuba, Stephen G Swisher, Ara A Vaporciyan, Heather Y Lin, Jing Wang, Don L Gibbons, Jiun-Kae Jack Lee, Nadim J Ajami, Jennifer A Wargo, James P Allison, Padmanee Sharma, Humam Kadara, John Victor Heymach, Boris Sepesi
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial. Nature medicine 29 (3) (2023)
Blessie Elizabeth Nelson, Jason Roszik, Filip Janku, David S Hong, Shumei Kato, Aung Naing, Sarina Piha-Paul, Siqing Fu, Apostolia-Maria Tsimberidou, Maria Cabanillas, Naifa Lamki Busaidy, Milind Javle, Lauren Averett Byers, John Victor Heymach, Funda Meric-Bernstam, Vivek Subbiah
BRAF v600E-mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study. NPJ precision oncology 7 (1) (2023)
Cascone Tina, Cheuk H Leung, Annikka Weissferdt, Apar Pataer, Brett W Carter, Myrna C B Godoy, Hope Feldman, William N William, Yuanxin Xi, Sreyashi Basu, Jing Jing Sun, Shalini S Yadav, Frank R Rojas Alvarez, Younghee Lee, Aditya K Mishra, Lili Chen, Monika Pradhan, Haiping Guo, Ansam Sinjab, Nicolas Zhou, Marcelo Vailati Negrão, Xiuning Li, Carl M Gay, Anne S Tsao, Lauren Averett Byers, Mehmet Altan, Bonnie S Glisson, Frank V Fossella, Yasir Y Elamin, George Blumenschein, Jianjun Zhang, Ferdinandos Skoulidis, Jia Wu, Reza J Mehran, David C Rice, Garrett L Walsh, Wayne L Hofstetter, Ravi Rajaram, Mara B Antonoff, Junya Fujimoto, Luisa Maren Solis Soto, Edwin Roger Parra Cuentes, Cara L Haymaker, Ignacio I Wistuba, Stephen G Swisher, Ara A Vaporciyan, Heather Y Lin, Jing Wang, Don L Gibbons, Jiun-Kae Jack Lee, Nadim J Ajami, Jennifer A Wargo, James P Allison, Padmanee Sharma, Humam Kadara, John Victor Heymach, Boris Sepesi
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial. Nature medicine 29 (3) (2023)
Bingnan Zhang, C Allison Stewart, Qi Wang, Robert J Cardnell, Pedro Rocha, Junya Fujimoto, Luisa M Solis Soto, Runsheng Wang, Veronica Novegil, Peter Ansell, Lei He, Luisa Fernandez, Adam Jendrisak, Cole Gilbertson, Joseph D Schonhoft, Jiyun Byun, Joshua Jones, Amanda K L Anderson, Ana Aparicio, Hai Tran, Marcelo V Negrao, Jianjun Zhang, Wei-Lien Wang, Ignacio I Wistuba, Jing Wang, Rick Wenstrup, Lauren Averett Byers, Carl M Gay
Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer. British journal of cancer 127 (3) (2022)
Stephanie Tzouanas Schmidt, Neal Akhave, Ryan E Knightly, Alexandre Reuben, Natalie I Vokes, Jianhua Zhang, Jun Li, Junya Fujimoto, Lauren Averett Byers, Beatriz Sanchez-Espiridion, Lixia Diao, Jing Wang, Lorenzo Federico, Marie-Andree Forget, Daniel J McGrail, Annikka Weissferdt, Shiaw-Yih Lin, Younghee Lee, Erika Suzuki, Jeffrey J Kovacs, Carmen Behrens, Ignacio I Wistuba, Andrew Futreal, Ara Vaporciyan, Boris Sepesi, John Victor Heymach, Chantale Bernatchez, Cara L Haymaker, Cascone Tina, Jianjun Zhang, Christopher A Bristow, Timothy P Heffernan, Marcelo V Negrao, Don L Gibbons, null null
Shared Nearest Neighbors Approach and Interactive Browser for Network Analysis of a Comprehensive Non-Small-Cell Lung Cancer Data Set. JCO clinical cancer informatics 6 (2022)
Ming Chen, Runzhe Chen, Ying Jin, Jun Li, Xin Hu, Jianhua Zhang, Junya Fujimoto, Shawna Marie Hubert, Carl M Gay, Bo Zhu, Yanhua Tian, Nicholas McGranahan, Won-Chul Lee, Julie George, Xiao Hu, Yamei Chen, Meijuan Wu, Carmen Behrens, Chi-Wan Chow, Hoa H N Pham, Junya Fukuoka, Jia Wu, Edwin Roger Parra Cuentes, Latasha D Little, Curtis Gumbs, Xingzhi Song, Chang-Jiun Wu, Lixia Diao, Qi Wang, Robert Cardnell, Jianhua Zhang, Jing Wang, Xiuning Li, Don L Gibbons, John Victor Heymach, Jiun-Kae Jack Lee, William N William, Chao Cheng, Bonnie Glisson, Ignacio Wistuba, P Andrew Futreal, Roman K Thomas, Alexandre Reuben, Lauren Averett Byers, Jianjun Zhang
Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer. Nature communications 12 (1) (2021)
Suresh R Ramalingam, Silvia Novello, Salih Zeki Guclu, Dmitry Bentsion, Zanete Zvirbule, Maria Szilasi, Reyes Bernabe, Konstantinos Syrigos, Lauren Averett Byers, Philip Clingan, Jair Bar, Everett E Vokes, Ramaswamy Govindan, Martin Dunbar, Peter Ansell, Lei He, Xin Huang, Vasudha Sehgal, Jaimee Glasgow, Bruce A Bach, Julien Mazieres
Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (32) (2021)
Kasey R Cargill, C Allison Stewart, Elizabeth M Park, Kavya Ramkumar, Carl M Gay, Robert J Cardnell, Qi Wang, Lixia Diao, Li Shen, You-Hong Fan, Wai Kin Chan, Philip L Lorenzi, Trudy G Oliver, Jing Wang, Lauren Averett Byers
Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer. Cancer & metabolism 9 (1) (2021)
David H Peng, B Leticia Rodriguez, Lixia Diao, Pierre-Olivier Gaudreau, Aparna Padhye, Jessica M Konen, Joshua Kapere Ochieng, Caleb A Class, Jared F Fradette, Laura Gibson, Limo Chen, Jing Wang, Lauren Averett Byers, Don L Gibbons
Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers. Nature communications 12 (1) (2021)
Ansam Sinjab, Guangchun Han, Warapen Treekitkarnmongkol, Kieko Hara, Patrick M Brennan, Minghao Dang, Dapeng Hao, Linghua Wang, Enyu Dai, Hitoshi Dejima, Jianhua Zhang, Elena Bogatenkova, Beatriz Sanchez-Espiridion, Kyle Chang, Danielle R Little, Samer Bazzi, Linh M Tran, Kostyantyn Krysan, Carmen Behrens, Dzifa Y Duose, Edwin Roger Parra Cuentes, Maria Gabriela Raso, Luisa Maren Solis Soto, Junya Fukuoka, Boris Sepesi, Tina Cascone, Lauren Averett Byers, Don L Gibbons, Jichao Chen, Seyed Javad Moghaddam, Edwin Justin Ostrin, Daniel Rosen, John Victor Heymach, Paul Scheet, Steven M Dubinett, Junya Fujimoto, Ignacio I Wistuba, Christopher S Stevenson, Avrum Spira, Humam Kadara
Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing. Cancer discovery 11 (10) (2021)
Lauren Averett Byers, Dmitry Bentsion, Steven Gans, Konstantin Penkov, ChoonHee Son, Anne Sibille, Taofeek Kunle Owonikoko, Harry J M Groen, Carl M Gay, Junya Fujimoto, Patricia M de Groot, Martin Dunbar, Kingston Kang, Lei He, Vasudha Sehgal, Jaimee Glasgow, Bruce Allen Bach, Peter Michael Ellis
Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (14) (2021)
Jessica M Konen, B Leticia Rodriguez, Aparna Padhye, Joshua K Ochieng, Laura Gibson, Lixia Diao, Natalie Wall Fowlkes, Jared F Fradette, David H Peng, Robert J Cardnell, Jeffrey J Kovacs, Jing Wang, Lauren Averett Byers, Don L Gibbons
Dual Inhibition of MEK and AXL Targets Tumor Cell Heterogeneity and Prevents Resistant Outgrowth Mediated by the Epithelial-to-Mesenchymal Transition in NSCLC. Cancer research 81 (5) (2021)
Bingnan Zhang, Kavya Ramkumar, Robert John Cardnell, Carl Michael Gay, C Allison Stewart, Wei-Lien Wang, Junya Fujimoto, Ignacio I Wistuba, Lauren Averett Byers
A wake-up call for cancer DNA damage: the role of Schlafen 11 (SLFN11) across multiple cancers. British journal of cancer 125 (10) (2021)
Cascone Tina, William N William, Annikka Weissferdt, Cheuk H Leung, Heather Y Lin, Apar Pataer, Myrna C B Godoy, Brett W Carter, Lorenzo Federico, Alexandre Reuben, Md Abdul Wadud Khan, Hitoshi Dejima, Alejandro Francisco-Cruz, Edwin Roger Parra Cuentes, Luisa Maren Solis Soto, Junya Fujimoto, Hai T Tran, Neda Kalhor, Frank V Fossella, Frank E Mott, Anne S Tsao, George Blumenschein, Xiuning Le, Jianjun Zhang, Ferdinandos Skoulidis, Jonathan M Kurie, Mehmet Altan, Charles Lu, Bonnie S Glisson, Lauren Averett Byers, Yasir Y Elamin, Reza J Mehran, David C Rice, Garrett L Walsh, Wayne L Hofstetter, Jack A Roth, Mara B Antonoff, Humam Kadara, Cara L Haymaker, Chantale Bernatchez, Nadim J Ajami, Robert R Jenq, Padmanee Sharma, James P Allison, P Andrew Futreal, Jennifer A Wargo, Ignacio I Wistuba, Stephen G Swisher, Jiun-Kae Jack Lee, Don L Gibbons, Ara A Vaporciyan, John Victor Heymach, Boris Sepesi
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial. Nature medicine 27 (3) (2021)
Sandra Cristea, Garry L Coles, Daniel Hornburg, Maya Gershkovitz, Julia Arand, Siqi Cao, Triparna Sen, Stuart Charles Williamson, Jun W Kim, Alexandros P Drainas, Andrew He, Laurent Le Cam, Lauren Averett Byers, Michael P Snyder, Kevin Contrepois, Julien Sage
The MEK5-ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer. Cancer research 80 (6) (2020)
David H Peng, Bertha Leticia Rodriguez, Lixia Diao, Limo Chen, Jing Wang, Lauren Averett Byers, Ying Wei, Harold A Chapman, Mitsuo Yamauchi, Carmen Behrens, Maria Gabriela Raso, Luisa Maren Solis Soto, Edwin Roger Parra Cuentes, Ignacio I Wistuba, Jonathan M Kurie, Don L Gibbons
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion. Nature communications 11 (1) (2020)
Kavya Ramkumar, C Allison Stewart, Kasey R Cargill, Carminia M Della Corte, Qi Wang, Li Shen, Lixia Diao, Robert J Cardnell, David H Peng, B Leticia Rodriguez, You-Hong Fan, John Victor Heymach, Carl M Gay, Don L Gibbons, Lauren Averett Byers
AXL Inhibition Induces DNA Damage and Replication Stress in Non-Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR Inhibitors. Molecular cancer research : MCR 19 (3) (2020)
Jose M Pacheco, Lauren Averett Byers
Temozolomide plus PARP Inhibition in Small-Cell Lung Cancer: Could Patient-Derived Xenografts Accelerate Discovery of Biomarker Candidates? Cancer discovery 9 (10) (2019)